Type I diabetes mellitus. A chronic autoimmune disease.
暂无分享,去创建一个
[1] M. Dorf,et al. The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. , 1986, Science.
[2] G. Eisenbarth,et al. First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. , 1985, The New England journal of medicine.
[3] D. R. Gamble,et al. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. , 1985, The New England journal of medicine.
[4] J. Nerup,et al. Cytokines Cause Functional and Structural Damage to Isolated Islets of Langerhans , 1985, Allergy.
[5] J. Seidman,et al. Major histocompatibility complex restriction fragment length polymorphisms define three diabetogenic haplotypes in BB and BBN rats , 1985, The Journal of experimental medicine.
[6] R. Dluhy,et al. Ia-positive T lymphocytes in recently diagnosed idiopathic Addison's disease. , 1984, The American journal of medicine.
[7] B. Myers,et al. Cyclosporine-associated chronic nephropathy. , 1984, The New England journal of medicine.
[8] B. Haynes,et al. Ia+ T cells in new onset Graves' disease. , 1984, The Journal of clinical endocrinology and metabolism.
[9] N. Maclaren,et al. ISLET-CELL ANTIBODIES ARE SELDOM TRANSIENT , 1984, The Lancet.
[10] R. Akeson,et al. Characterization of monoclonal antibody 3G5 and utilization of this antibody to immobilize pancreatic islet cell gangliosides in a solid phase radioassay. , 1984, Endocrinology.
[11] A. Laupacis,et al. Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. , 1984, Science.
[12] T. Starzl,et al. REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY , 1984, The Lancet.
[13] J. Dausset,et al. Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[14] B. Trapp,et al. IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[15] J. Palmer,et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. , 1983, Science.
[16] Å. Lernmark,et al. Inhibition of insulin release after passive transfer of immunoglobulin from insulin-dependent diabetic children to mice. , 1983, The Journal of clinical endocrinology and metabolism.
[17] L. Chiovato,et al. Lectin-induced expression of DR antigen on human cultured follicular thyroid cells , 1983, Nature.
[18] P. A. Peterson,et al. HLA-D region β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals , 1983, Nature.
[19] W. Chick,et al. Passive transfer of diabetes in the BB/W rat. , 1983, Science.
[20] N. Gregson,et al. IgM paraproteins with immunological specificity for a Schwann cell component and peripheral nerve myelin in patients with polyneuropathy , 1983, Journal of the Neurological Sciences.
[21] J. Mordes,et al. Transfusions of whole blood prevent spontaneous diabetes mellitus in the BB/W rat. , 1983, Science.
[22] G. Eisenbarth,et al. Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. , 1983, The New England journal of medicine.
[23] D. Pyke,et al. HLA-DR typing in identical twins with insulin-dependent diabetes: difference between concordant and discordant pairs. , 1983, British medical journal.
[24] Å. Lernmark,et al. Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children. , 1983, British medical journal.
[25] E. Yunis,et al. Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[26] H. Birgens,et al. Identification of a cold agglutinin with anti-Pr3 specificity. , 2009, Scandinavian journal of haematology.
[27] T. Waldmann,et al. A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor , 1982, Nature.
[28] P. Vitti,et al. Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[29] G. Eisenbarth,et al. Expression of receptors for tetanus toxin and monoclonal antibody A2B5 by pancreatic islet cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[30] S. Baekkeskov,et al. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins , 1982, Nature.
[31] S. Gupta,et al. Deficiency of suppressor T-cells in insulin-dependent diabetes mellitus: an analysis with monoclonal antibodies. , 1982, Immunology letters.
[32] B. Haynes,et al. Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus. , 1982, The New England journal of medicine.
[33] J. McNally,et al. EVIDENCE FOR A LONG PREDIABETIC PERIOD IN TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS , 1981, The Lancet.
[34] T. Seemayer,et al. Spontaneous diabetes mellitus syndrome in the rat. I. Association with the major histocompatibility complex , 1981, The Journal of experimental medicine.
[35] W. Silvers,et al. Prevention of Diabetes in Rats by Bone Marrow Transplantation , 1981, Annals of surgery.
[36] J. Shelhamer,et al. Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. , 1981, Journal of immunology.
[37] R. Scearce,et al. Cytotoxic antibodies to cloned rat islet cells in serum of patients with diabetes mellitus. , 1981, The Journal of clinical investigation.
[38] F. Ginsberg-Fellner,et al. Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. , 1980, The New England journal of medicine.
[39] M. Molitch,et al. HLA factors in non-insulin-dependent diabetes mellitus. , 1980 .
[40] T. Onodera,et al. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. , 1979, The New England journal of medicine.
[41] Å. Lernmark,et al. Islet-cell-surface antibodies in juvenile diabetes mellitus. , 1978, The New England journal of medicine.
[42] T. Strom,et al. Specific insulin binding site on T and B lymphocytes as a marker of cell activation , 1978, Nature.
[43] E. Marliss,et al. The spontaneously diabetic Wistar rat (the "BB" rat). Studies prior to and during development of the overt syndrome. , 1978, Diabetologia.
[44] W. Irvine. CLASSIFICATION OF DIABETES MELLITUS , 1977, The Lancet.
[45] W. Irvine,et al. PANCREATIC ISLET-CELL ANTIBODY AS A MARKER FOR ASYMPTOMATIC AND LATENT DIABETES AND PREDIABETES , 1976, The Lancet.
[46] E. Barnes,et al. Antibodies to pancreatic islet cells in insulin-dependent diabetics with coexistent autoimmune disease. , 1974, Lancet.
[47] D. Doniach,et al. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. , 1974, Lancet.
[48] J. Neel. The genetics of diabetes mellitus. , 1970, Advances in metabolic disorders.
[49] Attwater Hl. Surgery of urethral stricture. , 1948 .